Quality Assessment of Clinical Practice Guidelines for Integrative Medicine in China: A Systematic R

来源 :中国结合医学杂志(英文版) | 被引量 : 0次 | 上传用户:gaolch011
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To assess the quality of integrative medicine clinical practice guidelines (CPGs) published before 2014.Methods:A systematic search of the scientific literature published before 2014 was conducted to select integrative medicine CPGs.Four major Chinese integrated databases and one guideline database were searched:the Chinese Biomedical Literature Database (CBM),the China National Knowledge Infrastructure (CNKI),China Science and Technology Journal Database (VIP),Wanfang Data,and the China Guideline Clearinghouse (CGC).Four reviewers independently assessed the quality of the included guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE) Ⅱ Instrument.Overall consensus among the reviewers was assessed using the intra-class correlation coefficient (ICC).Results:A total of 41 guidelines published from 2003 to 2014 were included.The overall consensus among the reviewers was good [ICC:0.928;95% confidence interval (CI):0.920 to 0.935].The scores on the 6 AGREE domains were:17% for scope and purpose (range:6% to 32%),11% for stakeholder involvement (range:0 to 24%),10% for rigor of development (range:3% to 22%),39%for clarity and presentation (range:25% to 64%),11% for applicability (range:4% to 24%),and 1% for editorial independence (range:0 to 15%).Conclusions:The quality of integrative medicine CPGs was low,the development of integrative medicine CPGs should be guided by systematic methodology.More emphasis should be placed on multi-disciplinary guideline development groups,quality of evidence,management of funding and conflicts of interest,and guideline updates in the process of developing integrative medicine CPGs in China.
其他文献